Itrafaze 200mg Capsule contains Itraconazole, a broad-spectrum triazole antifungal agent effective against a wide range of fungal infections. It works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting cell membrane formation and leading to fungal cell death. Itrafaze is indicated for the treatment of various systemic and superficial mycoses, including aspergillosis, blastomycosis, histoplasmosis, onychomycosis, and candidiasis. The 200mg dosage is typically prescribed for adult patients requiring potent antifungal therapy. Itrafaze should be administered orally with food to enhance absorption. It is important to adhere to the prescribed duration of therapy to ensure complete eradication of the infection and to prevent resistance development. Caution is advised in patients with hepatic impairment or congestive heart failure, as itraconazole may exacerbate these conditions. Potential adverse effects include gastrointestinal disturbances, headache, rash, and elevated liver enzymes. Drug interactions are significant due to itraconazole’s inhibition of cytochrome P450 enzymes; thus, concomitant use with certain medications such as statins, benzodiazepines, and some antiretrovirals requires careful monitoring or dose adjustments. Itrafaze 200mg Capsule should be used under strict medical supervision to ensure safety and efficacy.